Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma

被引:12
|
作者
Dragutinovic, Vesna V. [1 ]
Tatic, Svetislav B. [2 ]
Nikolic-Mandic, Snezana [3 ]
Savin, Svetlana [4 ]
Cvejic, Dubravka [4 ]
Dunderovic, Dusko [2 ]
Gajic, Milan [5 ]
Paunovic, Ivan [6 ]
机构
[1] Univ Belgrade, Inst Med Chem, Fac Med, Belgrade, Serbia
[2] Univ Belgrade, Fac Med, Inst Pathol, Belgrade, Serbia
[3] Univ Belgrade, Fac Chem, Belgrade, Serbia
[4] Univ Belgrade, Inst Applicat Nucl Energy INEP, Belgrade, Serbia
[5] Univ Belgrade, Fac Med, Inst Med Stat & Informat, Belgrade, Serbia
[6] Clin Ctr Serbia, Ctr Endocrine Surg, Clin Endocrinol Diabet & Dis Metab, Belgrade, Serbia
关键词
Papillary thyroid carcinoma; Matrix metalloproteinase-9; Trace elements (Cu and Zn); Immunohistochemistry; MATRIX METALLOPROTEINASES; BREAST-TISSUE; EXPRESSION; ACTIVATION; COPPER; ZINC; GALECTIN-3; INHIBITORS;
D O I
10.1007/s12011-012-9404-y
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The most common histological variants of papillary thyroid carcinoma (PTC), classical (CPTC) and follicular (FPTC), have different diagnostic features, molecular biology, and prognosis. Matrix metalloproteinase-9 (MMP-9) endopeptidase which degrades the components of the extracellular matrix is essential in the invasive growth and metastasizing of malignant tumors. The serum copper (Cu)/zinc (Zn) ratios are sensitive diagnostic and prognostic indicators in oncology since Cu- and Zn-dependent enzymes play important roles in the genesis and the progression of tumors. The aim of this study was to examine the expressions of MMP-9 in tissues of CPTC and FPTC, as well as to determine the Cu/Zn ratios in the same samples. MMP-9 was determined immunohistochemically, and the concentrations of copper and zinc in thyroid tissue were determined by means of flame atomic absorption spectrometry. The results obtained revealed significantly higher expressions of MMP-9 in CPTC in comparison with FPTC, as well as higher Cu/Zn ratios in CPTC than in FPTC. Thus, determining MMP-9 activities and the Cu/Zn ratios could improve the accuracy of the standard histopathological diagnosis of these two types of PTC.
引用
收藏
页码:29 / 33
页数:5
相关论文
共 9 条
  • [1] Matrix Metalloproteinase-9 and the Cu/Zn Ratio as Ancillary Diagnostic Tools in Distinguishing Between the Classical and Follicular Variants of Papillary Thyroid Carcinoma
    Vesna V. Dragutinović
    Svetislav B. Tatić
    Snežana Nikolić-Mandić
    Svetlana Savin
    Dubravka Cvejić
    Duško Dunđerović
    Milan Gajić
    Ivan Paunović
    Biological Trace Element Research, 2012, 149 : 29 - 33
  • [2] Immunohistochemical analysis of matrix metalloproteinase-9 predicts papillary thyroid carcinoma prognosis
    Liu, Xingkai
    Su, Chang
    Xu, Jing
    Zhou, Dan
    Yan, He
    Li, Wei
    Chen, Guihui
    Zhang, Nan
    Xu, Dahai
    Hu, Haixia
    ONCOLOGY LETTERS, 2019, 17 (02) : 2308 - 2316
  • [3] Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis
    Jinxu Wen
    Xiaoru Qin
    Jiayi Zhang
    Xiaoyong Wu
    Xuemin Yan
    Kewen Lu
    Pei Yang
    Shuaichong Ji
    Xiangdong Zhao
    Yuexin Wang
    World Journal of Surgical Oncology, 21
  • [4] Clinical significance of matrix metalloproteinase-9 expression in papillary thyroid carcinoma: a meta-analysis
    Wen, Jinxu
    Qin, Xiaoru
    Zhang, Jiayi
    Wu, Xiaoyong
    Yan, Xuemin
    Lu, Kewen
    Yang, Pei
    Ji, Shuaichong
    Zhao, Xiangdong
    Wang, Yuexin
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2023, 21 (01)
  • [5] Pleural fluid matrix metalloproteinase-9 levels and cancer ratio as diagnostic tools for malignant pleural effusion
    Binharyanto, Adlan Pratama
    Putra, Ngakan Putu Parsama
    Rakhma, Sastia
    Putra, Christian Surya Eka
    ONCOLOGY IN CLINICAL PRACTICE, 2025,
  • [6] The Ubiquitin Ligase CHIP Accelerates Papillary Thyroid Carcinoma Metastasis via the Transgelin-Matrix Metalloproteinase-9 Axis
    Zhan, Shaohua
    Yang, Yan
    Deng, Shuwei
    Liu, Xinnan
    Cui, Liyan
    Wang, Tianxiao
    JOURNAL OF PROTEOME RESEARCH, 2025, 24 (02) : 589 - 598
  • [7] Immunohistochemical levels of cyclo-oxygenase-2, matrix metalloproteinase-9 and vascular endothelial growth factor in papillary thyroid carcinoma and their clinicopathological correlations
    Meng, Xian-Ying
    Zhang, Qiang
    Li, Qun
    Lin, Shan
    Li, Jie
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2014, 42 (03) : 619 - 627
  • [8] Correlations between papillary thyroid cancer and peripheral blood levels of matrix metalloproteinase-2, matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-1, and tissue inhibitor of metalloproteinase-2
    Zhou Shao-fei
    Hu San-yuan
    Ma Lei
    Miao Lei
    Mao Wei-zheng
    CHINESE MEDICAL JOURNAL, 2013, 126 (10) : 1925 - 1929
  • [9] Epidermal growth factor stimulates matrix metalloproteinase-9 expression and invasion in human follicular thyroid carcinoma cells through Focal adhesion kinase
    Rothhut, Bernard
    Ghoneim, Christelle
    Antonicelli, Frank
    Soula-Rothhut, Mahdhia
    BIOCHIMIE, 2007, 89 (05) : 613 - 624